dysmotility in the CRSTsyndrome which was reported by Winterbauer (2) in 1964 and consisted of the associated findings of calcinosis, Raynaud's phenomenon, sclerodactyly and telangiectasia. He concluded that CRESTsyndrome was a more informative designation than the CRST syndrome. Rodnan (3) used CRESTsyndrome as a subset of systemic sclerosis (SSc). Moroi et al (4) Shoji et al (8) reported that clinical and serological features of ACA-positive PBC-CRESToverlap syndrome were different from ACA-negative PBC-CRESTand PBC-non CREST patients. The frequencies of Raynaud's phenomenon and asymptomatic PBCin ACA-positive patients were higher than ACA-negative PBC patients. The predominant HLAtype in Japanese patients with PBC-CREST overlap syndrome is a controversial subject between this issue and another paper (9) . The postulated autoimmune mechanisms behind these conditions are poorly understood. Recently, Mayo et al (10) reported that overrepresentation of one T cell receptor beta chain variable region, TCRBV3, was documented in patients with PBC and/or CREST.This study demonstrated that the T cell repertoire of patients with PBCand CRESTwas characterized by expanded clonal populations of CD8 (+)TCRBV3 (+) T cells.
CRESTsyndrome is a unique variant of SSc because of high frequencies of ACAand PBC.
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